International Clinical Trial: A Single-Arm, Open-Label, Phase II Clinical Study of Utidelone and Bevacizumab With or Without Etoposide in Patients With Brain Metastases From Malignant Solid Tumors

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07449481) titled 'A Single-Arm, Open-Label, Phase II Clinical Study of Utidelone and Bevacizumab With or Without Etoposide in Patients With Brain Metastases From Malignant Solid Tumors' on Feb. 27.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Tianjin Medical University Cancer Institute and Hospital

Condition: Malignant Solid Tumor Brain Metastasis Microtubule Inhibitors Anti-angiogenic Targeted Drugs

Intervention: Drug: Utidelone

Recruitment Status: Not recruiting

Phase: Phase 2

Date...